Unknown

Dataset Information

0

Succinylated chitosan derivative has local protective effects on intestinal inflammation.


ABSTRACT: We have previously reported on the anti-inflammatory effects of a water-soluble chitosan derivative, zwitterionic chitosan (ZWC). In the present study, we hypothesized that orally-administered ZWC would provide local anti-inflammatory effects in the intestinal lumen. ZWC indeed showed anti-inflammatory effects in various in-vitro models including peritoneal macrophages, engineered THP1 monocytes, and Caco-2 cells. In Caco-2 cells, ZWC applied before the lipopolysaccharide (LPS) challenge was more effective than when it was applied after it in preventing LPS-induced cell damage. When administered to mice via drinking water as a prophylactic measure, ZWC protected the animals from 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis, helping them to recover the body weight, restore the gross and histological appearance of the colon, and generate FoxP3+ T cells. In contrast, orally-administered ZWC did not protect the animals from LPS-induced systemic inflammation. These results indicate that orally-administered ZWC reaches the colon with minimal absorption through the upper gastrointestinal tract and provides a local anti-inflammatory effect.

SUBMITTER: Hyun H 

PROVIDER: S-EPMC5810976 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Succinylated chitosan derivative has local protective effects on intestinal inflammation.

Hyun Hyesun H   Hashimoto-Hill Seika S   Kim Myunghoo M   Tsifansky Michael D MD   Kim Chang H CH   Yeo Yoon Y  

ACS biomaterials science & engineering 20170605 8


We have previously reported on the anti-inflammatory effects of a water-soluble chitosan derivative, zwitterionic chitosan (ZWC). In the present study, we hypothesized that orally-administered ZWC would provide local anti-inflammatory effects in the intestinal lumen. ZWC indeed showed anti-inflammatory effects in various <i>in-vitro</i> models including peritoneal macrophages, engineered THP1 monocytes, and Caco-2 cells. In Caco-2 cells, ZWC applied before the lipopolysaccharide (LPS) challenge  ...[more]

Similar Datasets

| S-EPMC8008224 | biostudies-literature
| S-EPMC4121323 | biostudies-literature
| S-EPMC9403564 | biostudies-literature
| S-EPMC7911331 | biostudies-literature
| S-EPMC7178247 | biostudies-literature
| S-EPMC8698467 | biostudies-literature
| S-EPMC7567035 | biostudies-literature
| S-EPMC7432940 | biostudies-literature
| S-EPMC7032234 | biostudies-literature
| S-EPMC2709990 | biostudies-literature